BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

111 related articles for article (PubMed ID: 26345631)

  • 21. Early-Stage Induction of SWI/SNF Mutations during Esophageal Squamous Cell Carcinogenesis.
    Nakazato H; Takeshima H; Kishino T; Kubo E; Hattori N; Nakajima T; Yamashita S; Igaki H; Tachimori Y; Kuniyoshi Y; Ushijima T
    PLoS One; 2016; 11(1):e0147372. PubMed ID: 26812616
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Comprehensive assessment of the expression of the SWI/SNF complex defines two distinct prognostic subtypes of ovarian clear cell carcinoma.
    Abou-Taleb H; Yamaguchi K; Matsumura N; Murakami R; Nakai H; Higasa K; Amano Y; Abiko K; Yoshioka Y; Hamanishi J; Koshiyama M; Baba T; Yamada R; Matsuda F; Konishi I; Mandai M
    Oncotarget; 2016 Aug; 7(34):54758-54770. PubMed ID: 27340867
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Two related ARID family proteins are alternative subunits of human SWI/SNF complexes.
    Wang X; Nagl NG; Wilsker D; Van Scoy M; Pacchione S; Yaciuk P; Dallas PB; Moran E
    Biochem J; 2004 Oct; 383(Pt 2):319-25. PubMed ID: 15170388
    [TBL] [Abstract][Full Text] [Related]  

  • 24. ARID1B as a Potential Therapeutic Target for ARID1A-Mutant Ovarian Clear Cell Carcinoma.
    Sato E; Nakayama K; Razia S; Nakamura K; Ishikawa M; Minamoto T; Ishibashi T; Yamashita H; Iida K; Kyo S
    Int J Mol Sci; 2018 Jun; 19(6):. PubMed ID: 29890703
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Characterization of SWI/SNF protein expression in human breast cancer cell lines and other malignancies.
    Decristofaro MF; Betz BL; Rorie CJ; Reisman DN; Wang W; Weissman BE
    J Cell Physiol; 2001 Jan; 186(1):136-45. PubMed ID: 11147808
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Loss of special AT-rich binding protein 1 expression is a marker of poor survival in lung cancer.
    Selinger CI; Cooper WA; Al-Sohaily S; Mladenova DN; Pangon L; Kennedy CW; McCaughan BC; Stirzaker C; Kohonen-Corish MR
    J Thorac Oncol; 2011 Jul; 6(7):1179-89. PubMed ID: 21597389
    [TBL] [Abstract][Full Text] [Related]  

  • 27. The reversible epigenetic silencing of BRM: implications for clinical targeted therapy.
    Glaros S; Cirrincione GM; Muchardt C; Kleer CG; Michael CW; Reisman D
    Oncogene; 2007 Oct; 26(49):7058-66. PubMed ID: 17546055
    [TBL] [Abstract][Full Text] [Related]  

  • 28. SWI/SNF chromatin remodeling complex is critical for the expression of microphthalmia-associated transcription factor in melanoma cells.
    Vachtenheim J; Ondrusová L; Borovanský J
    Biochem Biophys Res Commun; 2010 Feb; 392(3):454-9. PubMed ID: 20083088
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Loss of ARID1B and SMARCB1 expression are specific for the diagnosis of dedifferentiated/undifferentiated carcinoma in tumours of the upper gynaecological tract and cervix.
    Kang EY; Tessier-Cloutier B; Duggan MA; Stewart CJR; Lee CH; Köbel M
    Histopathology; 2021 Aug; 79(2):160-167. PubMed ID: 33432679
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Alterations of the SWI/SNF chromatin remodelling subunit-BRG1 and BRM in hepatocellular carcinoma.
    Endo M; Yasui K; Zen Y; Gen Y; Zen K; Tsuji K; Dohi O; Mitsuyoshi H; Tanaka S; Taniwaki M; Nakanuma Y; Arii S; Yoshikawa T
    Liver Int; 2013 Jan; 33(1):105-17. PubMed ID: 23088494
    [TBL] [Abstract][Full Text] [Related]  

  • 31. BRG1 and BRM loss selectively impacts RB and P53, respectively: BRG1 and BRM have differential functions
    Marquez-Vilendrer SB; Rai SK; Gramling SJ; Lu L; Reisman DN
    Oncoscience; 2016; 3(11-12):337-350. PubMed ID: 28105458
    [TBL] [Abstract][Full Text] [Related]  

  • 32. PD-1 and PD-L1 Expression in NSCLC Indicate a Favorable Prognosis in Defined Subgroups.
    Schmidt LH; Kümmel A; Görlich D; Mohr M; Bröckling S; Mikesch JH; Grünewald I; Marra A; Schultheis AM; Wardelmann E; Müller-Tidow C; Spieker T; Schliemann C; Berdel WE; Wiewrodt R; Hartmann W
    PLoS One; 2015; 10(8):e0136023. PubMed ID: 26313362
    [TBL] [Abstract][Full Text] [Related]  

  • 33. [SWI/SNF Complex Gene Mutations Promote the Liver Metastasis 
of Non-small Cell Lung Cancer Cells in NSI Mice].
    Gao L; Xie Z; Lin S; Lv Z; Zhou W; Chen J; Zhu L; Zhang L; Zeng P; Huang X; Yan W; Chen Y; Lu D; Zhang S; Guo W; Li P; Zhang X
    Zhongguo Fei Ai Za Zhi; 2023 Oct; 26(10):753-764. PubMed ID: 37989338
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Prognostic significance of TAZ expression in resected non-small cell lung cancer.
    Xie M; Zhang L; He CS; Hou JH; Lin SX; Hu ZH; Xu F; Zhao HY
    J Thorac Oncol; 2012 May; 7(5):799-807. PubMed ID: 22481233
    [TBL] [Abstract][Full Text] [Related]  

  • 35. SWI/SNF chromatin-remodeling factors induce changes in DNA methylation to promote transcriptional activation.
    Banine F; Bartlett C; Gunawardena R; Muchardt C; Yaniv M; Knudsen ES; Weissman BE; Sherman LS
    Cancer Res; 2005 May; 65(9):3542-7. PubMed ID: 15867346
    [TBL] [Abstract][Full Text] [Related]  

  • 36. [Evaluation of p63 expression in lung cancer by use of complementary DNA and tissue microarray].
    Yu YW; Garber ME; Schlüns K; Pacyna-Gengelbach M; Petersen I
    Zhonghua Bing Li Xue Za Zhi; 2004 Aug; 33(4):324-7. PubMed ID: 15363316
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Diversity in expression and prognostic significance of G1/S cyclins in human primary lung carcinomas.
    Dobashi Y; Jiang SX; Shoji M; Morinaga S; Kameya T
    J Pathol; 2003 Feb; 199(2):208-20. PubMed ID: 12533834
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Mammalian chromatin remodeling complex SWI/SNF is essential for enhanced expression of the albumin gene during liver development.
    Inayoshi Y; Miyake K; Machida Y; Kaneoka H; Terajima M; Dohda T; Takahashi M; Iijima S
    J Biochem; 2006 Feb; 139(2):177-88. PubMed ID: 16452305
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Dedifferentiation-like tubular and solid carcinoma of the stomach shows phenotypic divergence and association with deficient SWI/SNF complex.
    Huang SC; Chen KH; Ng KF; Lin IC; Chao YC; Yeh TS; Chuang HC; Chen TC
    Virchows Arch; 2022 Apr; 480(4):771-781. PubMed ID: 35122125
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Clinical significance of IGF1R expression in non-small-cell lung cancer.
    Nakagawa M; Uramoto H; Oka S; Chikaishi Y; Iwanami T; Shimokawa H; So T; Hanagiri T; Tanaka F
    Clin Lung Cancer; 2012 Mar; 13(2):136-42. PubMed ID: 22133293
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.